Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma
Crossref DOI link: https://doi.org/10.1007/s10147-017-1199-6
Published Online: 2017-10-31
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kobayashi, Hiroshi
Okuma, Tomotake
Oka, Hiroyuki
Hirai, Toshihide
Ohki, Takahiro
Ikegami, Masachika
Sawada, Ryoko
Shinoda, Yusuke
Akiyama, Toru
Sato, Kenji
Abe, Satoshi
Kawano, Hirotaka
Goto, Takahiro
Tanaka, Sakae
License valid from 2017-10-31